This inventor holds 2 USPTO granted patents. Top assignee: Il Yang Pharmaceutical Company, Ltd.. Active years: 1996-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1998
Title: The Innovative Mind of Hoon Chung: Advancements in Immunotherapy
Introduction: Hoon Chung, an esteemed inventor based in Seoul, South Korea, has made significant strides in the field of immunotherapy. With two patents to his name, Chung is at the forefront of developing natural solutions for enhancing immunity and combating tumors.
Latest Patents: One of Chung's latest inventions is a remarkable strain of Ganoderma lucidum, designated as IY 009, which produces a proteoglycan known as G009. This innovative product has been shown to possess antitumoral and immunostimulating effects. The proteoglycan G009 is composed of various saccharide components, including beta-glucose, alpha-glucose, galactose, alpha-mannose, and fructose, as well as essential protein components such as glycine, alanine, histidine, arginine, valine, aspartic acid, threonine, isoleucine, serine, leucine, glutamic acid, tyrosine, proline, phenylalanine, and methionine. This strain is registered with the accession number KCCM 10045, adding significant value to Chung's contributions in the realm of health and wellness.
Career Highlights: Hoon Chung works with Il Yang Pharmaceutical Company, Ltd., a well-respected organization in the pharmaceutical sector. His position at this innovative company allows him to focus on research and development aimed at producing groundbreaking medical solutions that can have a lasting impact on patient care.
Collaborations: Throughout his career, Chung has collaborated with distinguished colleagues such as Kwon Haeng Lee and Choon W Lee. Their combined efforts have contributed to advancing research in the field and bringing innovative ideas to fruition.
Conclusion: Hoon Chung's dedication to improving health outcomes through his innovative inventions makes him a prominent figure in the field of immunotherapy. His latest patent on Ganoderma lucidum exemplifies his commitment to leveraging natural resources for enhanced medical solutions. With continued collaboration and research, Chung is set to make an even greater impact in the medical community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile